Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Postoperative Sleep Disorders in Hypertensive Surgical Patients
ChiCTR2600128501Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in sleep disorder (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Postoperative sleep disturbances. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2600128501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128501.